Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionCullinan Associates Inc
Latest Disclosed Ownership25,516 shares
Latest Disclosed Value $ 8,977,759
Cullinan Associates Inc reports 18.07% decrease in ownership of AMGN / Amgen Inc.

On May 1, 2026 - Cullinan Associates Inc filed a 13F-HR form disclosing ownership of 25,516 shares of Amgen Inc. (MX:AMGN) valued at $8,977,759 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 31,143 shares of Amgen Inc.. This represents a change in shares of -18.07% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F Amgen COM 031162100 25,516 -5,627 -18.07 8,978 -11.93 0.7261
2026-01-30 2025-12-31 13F Amgen COM 031162100 31,143 -301 -0.96 10,193 14.88 0.6909
2025-10-27 2025-09-30 13F Amgen COM 031162100 31,444 -2,602 -7.64 8,873 -6.66 0.5778
2025-07-22 2025-06-30 13F Amgen COM 031162100 34,046 -477 -1.38 9,506 -11.61 0.6270
2025-04-22 2025-03-31 13F Amgen COM 031162100 34,523 -1,511 -4.19 10,756 14.52 0.7603
2025-01-24 2024-12-31 13F Amgen COM 031162100 36,034 -11,869 -24.78 9,392 -38.18 0.6029
2024-10-23 2024-09-30 13F Amgen COM 031162100 47,903 -3,111 -6.10 15,192 -4.69 0.8569
2024-07-10 2024-06-30 13F Amgen COM 031162100 51,014 -123,606 -70.79 15,939 -67.90 0.9019
2024-04-18 2024-03-31 13F Amgen COM 031162100 174,620 18,733 12.02 49,648 10.58 2.7841
2024-01-24 2023-12-31 13F Amgen COM 031162100 155,887 -10,968 -6.57 44,899 0.12 2.5033
2023-10-11 2023-09-30 13F Amgen COM 031162100 166,855 -43,567 -20.70 44,844 -4.01 2.6118
2023-07-14 2023-06-30 13F Amgen COM 031162100 210,422 -1,515 -0.71 46,718 -8.82 2.5679
2023-04-05 2023-03-31 13F Amgen COM 031162100 211,937 9,173 4.52 51,236 96,569.81 2.9931
2023-01-11 2022-12-31 13F Amgen COM 031162100 202,764 -517 -0.25 53 -99.88 2.9509
2022-10-19 2022-09-30 13F Amgen COM 031162100 203,281 732 0.36 45,820 -7.02 2.8936
2022-07-08 2022-06-30 13F Amgen COM 031162100 202,549 3,431 1.72 49,280 2.34 3.0127
2022-04-21 2022-03-31 13F Amgen COM 031162100 199,118 1,617 0.82 48,151 8.37 2.5265
2022-01-07 2021-12-31 13F Amgen COM 031162100 197,501 4,345 2.25 44,432 8.17 2.2618
2021-10-08 2021-09-30 13F Amgen COM 031162100 193,156 21,128 12.28 41,075 -2.04 2.2692
2021-07-07 2021-06-30 13F Amgen COM 031162100 172,028 11,171 6.94 41,932 4.77 2.3484
2021-04-20 2021-03-31 13F Amgen COM 031162100 160,857 -4,708 -2.84 40,023 5.14 2.3030
2021-01-14 2020-12-31 13F Amgen COM 031162100 165,565 -4,100 -2.42 38,067 -11.72 2.2835
2020-10-09 2020-09-30 13F Amgen COM 031162100 169,665 -2,750 -1.59 43,122 6.04 2.7799
2020-07-07 2020-06-30 13F Amgen COM 031162100 172,415 125,988 271.37 40,666 332.07 2.8521
2020-04-01 2020-03-31 13F Amgen COM 031162100 46,427 -3,830 -7.62 9,412 -22.31 0.7694
2020-01-15 2019-12-31 13F Amgen COM 031162100 50,257 641 1.29 12,115 26.18 0.8099
2019-10-01 2019-09-30 13F Amgen COM 031162100 49,616 -1,960 -3.80 9,601 1.02 0.6835
2019-07-16 2019-06-30 13F Amgen COM 031162100 51,576 671 1.32 9,504 -1.73 0.6898
2019-04-30 2019-03-31 13F Amgen COM 031162100 50,905 -1,280 -2.45 9,671 -4.80 0.7264
2019-01-11 2018-12-31 13F Amgen COM 031162100 52,185 -433 -0.82 10,159 -6.86 0.8389
2018-10-19 2018-09-30 13F Amgen COM 031162100 52,618 -8,007 -13.21 10,907 -2.54 0.7896
2018-07-09 2018-06-30 13F Amgen COM 031162100 60,625 -35,281 -36.79 11,191 -31.55 0.8563
2018-04-26 2018-03-31 13F Amgen COM 031162100 95,906 -820 -0.85 16,350 -2.80 1.2385
2018-01-17 2017-12-31 13F Amgen COM 031162100 96,726 -1,026 -1.05 16,821 -7.71 1.2352
2017-10-16 2017-09-30 13F Amgen COM 031162100 97,752 8,215 9.17 18,226 18.19 1.4037
2017-07-12 2017-06-30 13F Amgen COM 031162100 89,537 8,348 10.28 15,421 15.76 1.2008
2017-04-17 2017-03-31 13F Amgen COM 031162100 81,189 12,960 18.99 13,321 33.53 1.0860
2017-01-30 2016-12-31 13F Amgen COM 031162100 68,229 -1,376 -1.98 9,976 -14.08 0.8497
2016-10-03 2016-09-30 13F Amgen COM 031162100 69,605 -1,795 -2.51 11,611 6.88 0.9926
2016-07-01 2016-06-30 13F Amgen COM 031162100 71,400 10,680 17.59 10,864 19.33 0.8831
2016-05-20 2016-03-31 13F Amgen COM 031162100 60,720 6,450 11.89 9,104 3.34 0.7776
2016-01-12 2015-12-31 13F Amgen COM 031162100 54,270 13,129 31.91 8,810 54.81 0.7670
2015-10-05 2015-09-30 13F Amgen COM 031162100 41,141 771 1.91 5,691 -8.18 0.5198
2015-07-06 2015-06-30 13F AMGEN COM 031162100 40,370 1,250 3.20 6,198 -0.88 0.5112
2015-04-14 2015-03-31 13F Amgen COM 031162100 39,120 4,200 12.03 6,253 12.42 0.4851
2015-01-21 2014-12-31 13F Amgen Common 031162100 34,920 8,810 33.74 5,562 51.68 0.5887
2014-11-12 2014-09-30 13F Amgen Common 031162100 26,110 9,100 53.50 3,667 74.79 0.4177
2014-05-08 2014-03-31 13F Amgen Common 031162100 17,010 5,690 50.27 2,098 62.51 0.2386
2014-02-14 2013-12-31 13F Amgen Common 031162100 11,320 770 7.30 1,291 9.41 0.1497
2013-10-18 2013-09-30 13F Amgen Common 031162100 10,550 -3,850 -26.74 1,180 -16.96 0.1582
2013-08-13 2013-06-30 13F Amgen Common 031162100 14,400 14,400 1,421 0.1921
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.